Placenta derived mesenchymal stem cells in combination with polycaprolactone-20% tricalcium phosphate scaffolds for the treatment of critical-sized defects of the mandible

Eui Seok Lee, Byoung Moo Seo, Jae Suk Rim, Hyon Seok Jang, Jong Jin Kwon

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: Polycaprolactone-20% tricalcium phosphate (PCL-TCP) polymers allow for cellular adherence and differentiation and are adequate scaffolds for bone regeneration in tissue engineering strategies. The placenta contains multipotent stem cells. This study evaluated the utility of placenta derived mesenchymal stem cells (PDMSCs) seeded onto PCL-TCP scaffolds for bone tissue engineering. Materials and Methods: PDMSCs were isolated from placenta. PCL-TCP scaffolds with PDMSCs were implanted in full-thickness mandibular bone defects (2×2 cm) in minipigs. In the first experimental group, defects were treated with amnion-derived MSCs placed onto the scaffold, whereas in the second experimental group, defects were treated with deciduas-derived MSCs placed onto the scaffold. As a control, a third defect was treated with the scaffold only. Histological and radiographic examinations were performed twelve weeks post-implantation. Results: Soft radiographic measurements showed that experimental groups had twice the bone density of control group. Experimental groups had a statistically significant increased bone regeneration potential compared to control group in mandibular bone defects in minipigs. Micro CT showed that experimental groups had higher levels of percent of regenerated volume fraction, regenerated bone volumes and regenerated bone surface than control group. The histologic examination revealed the presence of regenerated bone at the central area of defect. Conclusion: PDMSCs seeded into the PCL-TCP scaffolds enhance bone regeneration in mandibular defects. Therefore PCL-TCP scaffold with placenta derived mesenchymal stem cels can increase bone regeneration.

Original languageEnglish
Pages (from-to)276-282
Number of pages7
JournalTissue Engineering and Regenerative Medicine
Volume7
Issue number3
Publication statusPublished - 2010 May 1

Fingerprint

Polycaprolactone
Stem cells
Mesenchymal Stromal Cells
Mandible
Scaffolds
Placenta
Bone
Phosphates
Bone Regeneration
Defects
Bone and Bones
Miniature Swine
Tissue Engineering
Control Groups
Multipotent Stem Cells
Scaffolds (biology)
Tissue engineering
Amnion
polycaprolactone
tricalcium phosphate

Keywords

  • Bone regeneration
  • Mesenchymal stem cells
  • Pcl-tcp scaffold
  • Placenta

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Biomedical Engineering

Cite this

Placenta derived mesenchymal stem cells in combination with polycaprolactone-20% tricalcium phosphate scaffolds for the treatment of critical-sized defects of the mandible. / Lee, Eui Seok; Seo, Byoung Moo; Rim, Jae Suk; Jang, Hyon Seok; Kwon, Jong Jin.

In: Tissue Engineering and Regenerative Medicine, Vol. 7, No. 3, 01.05.2010, p. 276-282.

Research output: Contribution to journalArticle

@article{3b9b6e8b2d9844598b415064ebc20d1f,
title = "Placenta derived mesenchymal stem cells in combination with polycaprolactone-20{\%} tricalcium phosphate scaffolds for the treatment of critical-sized defects of the mandible",
abstract = "Objectives: Polycaprolactone-20{\%} tricalcium phosphate (PCL-TCP) polymers allow for cellular adherence and differentiation and are adequate scaffolds for bone regeneration in tissue engineering strategies. The placenta contains multipotent stem cells. This study evaluated the utility of placenta derived mesenchymal stem cells (PDMSCs) seeded onto PCL-TCP scaffolds for bone tissue engineering. Materials and Methods: PDMSCs were isolated from placenta. PCL-TCP scaffolds with PDMSCs were implanted in full-thickness mandibular bone defects (2×2 cm) in minipigs. In the first experimental group, defects were treated with amnion-derived MSCs placed onto the scaffold, whereas in the second experimental group, defects were treated with deciduas-derived MSCs placed onto the scaffold. As a control, a third defect was treated with the scaffold only. Histological and radiographic examinations were performed twelve weeks post-implantation. Results: Soft radiographic measurements showed that experimental groups had twice the bone density of control group. Experimental groups had a statistically significant increased bone regeneration potential compared to control group in mandibular bone defects in minipigs. Micro CT showed that experimental groups had higher levels of percent of regenerated volume fraction, regenerated bone volumes and regenerated bone surface than control group. The histologic examination revealed the presence of regenerated bone at the central area of defect. Conclusion: PDMSCs seeded into the PCL-TCP scaffolds enhance bone regeneration in mandibular defects. Therefore PCL-TCP scaffold with placenta derived mesenchymal stem cels can increase bone regeneration.",
keywords = "Bone regeneration, Mesenchymal stem cells, Pcl-tcp scaffold, Placenta",
author = "Lee, {Eui Seok} and Seo, {Byoung Moo} and Rim, {Jae Suk} and Jang, {Hyon Seok} and Kwon, {Jong Jin}",
year = "2010",
month = "5",
day = "1",
language = "English",
volume = "7",
pages = "276--282",
journal = "Tissue Engineering and Regenerative Medicine",
issn = "1738-2696",
publisher = "Springer Science + Business Media",
number = "3",

}

TY - JOUR

T1 - Placenta derived mesenchymal stem cells in combination with polycaprolactone-20% tricalcium phosphate scaffolds for the treatment of critical-sized defects of the mandible

AU - Lee, Eui Seok

AU - Seo, Byoung Moo

AU - Rim, Jae Suk

AU - Jang, Hyon Seok

AU - Kwon, Jong Jin

PY - 2010/5/1

Y1 - 2010/5/1

N2 - Objectives: Polycaprolactone-20% tricalcium phosphate (PCL-TCP) polymers allow for cellular adherence and differentiation and are adequate scaffolds for bone regeneration in tissue engineering strategies. The placenta contains multipotent stem cells. This study evaluated the utility of placenta derived mesenchymal stem cells (PDMSCs) seeded onto PCL-TCP scaffolds for bone tissue engineering. Materials and Methods: PDMSCs were isolated from placenta. PCL-TCP scaffolds with PDMSCs were implanted in full-thickness mandibular bone defects (2×2 cm) in minipigs. In the first experimental group, defects were treated with amnion-derived MSCs placed onto the scaffold, whereas in the second experimental group, defects were treated with deciduas-derived MSCs placed onto the scaffold. As a control, a third defect was treated with the scaffold only. Histological and radiographic examinations were performed twelve weeks post-implantation. Results: Soft radiographic measurements showed that experimental groups had twice the bone density of control group. Experimental groups had a statistically significant increased bone regeneration potential compared to control group in mandibular bone defects in minipigs. Micro CT showed that experimental groups had higher levels of percent of regenerated volume fraction, regenerated bone volumes and regenerated bone surface than control group. The histologic examination revealed the presence of regenerated bone at the central area of defect. Conclusion: PDMSCs seeded into the PCL-TCP scaffolds enhance bone regeneration in mandibular defects. Therefore PCL-TCP scaffold with placenta derived mesenchymal stem cels can increase bone regeneration.

AB - Objectives: Polycaprolactone-20% tricalcium phosphate (PCL-TCP) polymers allow for cellular adherence and differentiation and are adequate scaffolds for bone regeneration in tissue engineering strategies. The placenta contains multipotent stem cells. This study evaluated the utility of placenta derived mesenchymal stem cells (PDMSCs) seeded onto PCL-TCP scaffolds for bone tissue engineering. Materials and Methods: PDMSCs were isolated from placenta. PCL-TCP scaffolds with PDMSCs were implanted in full-thickness mandibular bone defects (2×2 cm) in minipigs. In the first experimental group, defects were treated with amnion-derived MSCs placed onto the scaffold, whereas in the second experimental group, defects were treated with deciduas-derived MSCs placed onto the scaffold. As a control, a third defect was treated with the scaffold only. Histological and radiographic examinations were performed twelve weeks post-implantation. Results: Soft radiographic measurements showed that experimental groups had twice the bone density of control group. Experimental groups had a statistically significant increased bone regeneration potential compared to control group in mandibular bone defects in minipigs. Micro CT showed that experimental groups had higher levels of percent of regenerated volume fraction, regenerated bone volumes and regenerated bone surface than control group. The histologic examination revealed the presence of regenerated bone at the central area of defect. Conclusion: PDMSCs seeded into the PCL-TCP scaffolds enhance bone regeneration in mandibular defects. Therefore PCL-TCP scaffold with placenta derived mesenchymal stem cels can increase bone regeneration.

KW - Bone regeneration

KW - Mesenchymal stem cells

KW - Pcl-tcp scaffold

KW - Placenta

UR - http://www.scopus.com/inward/record.url?scp=84884583753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884583753&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 276

EP - 282

JO - Tissue Engineering and Regenerative Medicine

JF - Tissue Engineering and Regenerative Medicine

SN - 1738-2696

IS - 3

ER -